ANTIPLAQUETARIOS Y ANTICOAGULANTES PDF
Advanced search allows to you precisely focus your query. Search within a content type, and even narrow to one or more resources. You can also find results for. Resumo. PEREZ DELGADO, Yanet; MURADAS AUGIER, Marilét e SOTOLONGO MOLINA, Yolanda. Anticoagulant and antiplatelet agents: considerations in the. Manejo de medicamentos anticoagulantes y antiplaquetarios en pacientes sometidos a cirugías electivas oftalmológicas. Christine A Kiire,1.
|Published (Last):||1 October 2012|
|PDF File Size:||12.86 Mb|
|ePub File Size:||1.18 Mb|
|Price:||Free* [*Free Regsitration Required]|
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.
Management of acute coronary syndromes in developing countries: Recentemente, Chechik e cols. Terapia anticoagulante no TEV 7. Prevention of venous thromboembolism after major orthopedic surgery: Safety of clopidogrel being continued until antiplaqutarios time of coronary artery bypass grafting in patients with acute coronary syndrome: Stroke prevention in atrial fibrillation: Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin: Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: Espera-se que em 1.
Prevention of VTE in nonsurgical patients: Em dias subsequentes, a dose administrada de dalteparina foi de 5.
There was a problem providing the content you requested
Inhibition of platelet aggregation by combined therapy with aspirin and cilostazol after off-pump coronary artery bypass surgery. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. Guidelines on the management of valvular heart disease: Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
O uso de HNF em baixas doses 5.
Baseline risk of anticoagulatnes bleeding in non-ST-segment-elevation myocardial infarction: Apixaban versus warfarin in patients with atrial fibrillation. Anticoagulant prophylaxis to prevent asymptomatic deep vein thrombosis in hospitalized medical patients: Low-dose aspirin for preventing recurrent venous thromboembolism.
Systemic embolism and anticoagulant prophylaxis in rheumatic heart disease. Oral rivaroxaban for symptomatic venous thromboembolism. Effects of preoperative enoxaparin versus unfractionated heparin on bleeding indices in patients undergoing coronary artery bypass grafting.
What do we know and what can we do? Subsequent noncardiac operations and the risk of thromboembolism or hemorrhage. Relation between the time anticoagulantfs achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis.
Brazilian guidelines on antiplatelet and anticoagulant agents in cardiology
Prasugrel versus clopidogrel in patients with acute coronary syndromes. Anticoagulants; antiplatelet; surgical patient. Productos y servicios Libro: Preoperative thienopyridine use and outcomes after surgery: Fondaparinux combined with intermittent pneumatic compression vs. To update the information on perioperative behavior of patients treated with anticoagulant and antiaggregant drugs. No entanto, houve falha no recrutamento dos pacientes e o estudo foi interrompido precocemente. Arterioscler Thromb Vasc Biol.
Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction.
Fondaparinux versus enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: Randomized trial of warfarin, aspirin and clopidogrel in patients with chronic anticoagulanted failure: Ventricular dysfunction and the risk of stroke after myocardial infarction.
A multiple dose of prasugel CSa novel thienopyridine P2Y12 inhibitor, compared with clopidogrel in healthy humans. Perioperative blood transfusion and blood conservation in cardiac surgery: Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: Effect of fondaparinux 2.
Treatment and prevention of heparin-induced thrombocytopenia: Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents. Anticoagulant activity of Hirulog, a direct thrombin inhibitor, in humans. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Clinical durability of the pericardial xenograft valve: Resultados dos grandes estudos. Imperiale TF, Speroff T.
Intravenous heparin started within antiplaqketarios first 3 hours after onset of symptoms as a treatment for acute nonlacunar hemispheric cerebral infarctions.